141 related articles for article (PubMed ID: 29534999)
61. P2 receptors and platelet activation.
Kunapuli SP
ScientificWorldJournal; 2002 Feb; 2():424-33. PubMed ID: 12806027
[TBL] [Abstract][Full Text] [Related]
62. Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y
Peng J; Zhao L; Wang L; Chen H; Qiu Y; Wang J; Yang H; Liu J; Liu H
Eur J Med Chem; 2018 Oct; 158():302-310. PubMed ID: 30223118
[TBL] [Abstract][Full Text] [Related]
63. A new role for the A2b adenosine receptor in regulating platelet function.
Yang D; Chen H; Koupenova M; Carroll SH; Eliades A; Freedman JE; Toselli P; Ravid K
J Thromb Haemost; 2010 Apr; 8(4):817-27. PubMed ID: 20102488
[TBL] [Abstract][Full Text] [Related]
64. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
65. Pomolic acid, triterpenoid isolated from Licania pittieri, as competitive antagonist of ADP-induced aggregation of human platelets.
Alvarado-Castillo C; Estrada O; Carvajal E
Phytomedicine; 2012 Apr; 19(6):484-7. PubMed ID: 22402243
[TBL] [Abstract][Full Text] [Related]
66. Distinct Signaling Patterns of Allosteric Antagonism at the P2Y
Gao ZG; Jacobson KA
Mol Pharmacol; 2017 Nov; 92(5):613-626. PubMed ID: 28864555
[TBL] [Abstract][Full Text] [Related]
67. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice.
Léon C; Hechler B; Freund M; Eckly A; Vial C; Ohlmann P; Dierich A; LeMeur M; Cazenave JP; Gachet C
J Clin Invest; 1999 Dec; 104(12):1731-7. PubMed ID: 10606627
[TBL] [Abstract][Full Text] [Related]
68. Nucleotide P2Y
Liston TE; Hinz S; Müller CE; Holstein DM; Wendling J; Melton RJ; Campbell M; Korinek WS; Suresh RR; Sethre-Hofstad DA; Gao ZG; Tosh DK; Jacobson KA; Lechleiter JD
Purinergic Signal; 2020 Dec; 16(4):543-559. PubMed ID: 33129204
[TBL] [Abstract][Full Text] [Related]
69. Platelet P2Y
Ribes A; Garcia C; Gratacap MP; Kostenis E; Martinez LO; Payrastre B; Sénard JM; Galés C; Pons V
BMC Biol; 2023 Feb; 21(1):14. PubMed ID: 36721118
[TBL] [Abstract][Full Text] [Related]
70. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase.
Trumel C; Payrastre B; Plantavid M; Hechler B; Viala C; Presek P; Martinson EA; Cazenave JP; Chap H; Gachet C
Blood; 1999 Dec; 94(12):4156-65. PubMed ID: 10590060
[TBL] [Abstract][Full Text] [Related]
71. Reversible translocation of phosphoinositide 3-kinase to the cytoskeleton of ADP-aggregated human platelets occurs independently of Rho A and without synthesis of phosphatidylinositol (3,4)-bisphosphate.
Gachet C; Payrastre B; Guinebault C; Trumel C; Ohlmann P; Mauco G; Cazenave JP; Plantavid M; Chap H
J Biol Chem; 1997 Feb; 272(8):4850-4. PubMed ID: 9030542
[TBL] [Abstract][Full Text] [Related]
72. Association between P2Y1 and P2Y12 polymorphisms and acute myocardial infarction and ADP-induced platelet aggregation.
Su C; Zhang Z; Chen J; Tian M; Wu C; Zhang T
BMC Cardiovasc Disord; 2023 Jan; 23(1):41. PubMed ID: 36681816
[TBL] [Abstract][Full Text] [Related]
73. Rhizoma Bletillae polysaccharide elicits hemostatic effects in platelet-rich plasma by activating adenosine diphosphate receptor signaling pathway.
Dong L; Liu XX; Wu SX; Mei Y; Liu MJ; Dong YX; Huang JY; Li YJ; Huang Y; Wang YL; Liao SG
Biomed Pharmacother; 2020 Oct; 130():110537. PubMed ID: 32717630
[TBL] [Abstract][Full Text] [Related]
74. Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents.
Yang W; Wang Y; Lai A; Qiao JX; Wang TC; Hua J; Price LA; Shen H; Chen XQ; Wong P; Crain E; Watson C; Huang CS; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
J Med Chem; 2014 Jul; 57(14):6150-64. PubMed ID: 24931384
[TBL] [Abstract][Full Text] [Related]
75. Leptin-dependent platelet aggregation in healthy, overweight and obese subjects.
Corsonello A; Perticone F; Malara A; De Domenico D; Loddo S; Buemi M; Ientile R; Corica F
Int J Obes Relat Metab Disord; 2003 May; 27(5):566-73. PubMed ID: 12704400
[TBL] [Abstract][Full Text] [Related]
76. Genetic and pharmacologic evidence that Rac1 GTPase is involved in regulation of platelet secretion and aggregation.
Akbar H; Kim J; Funk K; Cancelas JA; Shang X; Chen L; Johnson JF; Williams DA; Zheng Y
J Thromb Haemost; 2007 Aug; 5(8):1747-55. PubMed ID: 17663742
[TBL] [Abstract][Full Text] [Related]
77. The Molecular Mechanism of P2Y1 Receptor Activation.
Yuan S; Chan HC; Vogel H; Filipek S; Stevens RC; Palczewski K
Angew Chem Int Ed Engl; 2016 Aug; 55(35):10331-5. PubMed ID: 27460867
[TBL] [Abstract][Full Text] [Related]
78. Two disparate ligand-binding sites in the human P2Y1 receptor.
Zhang D; Gao ZG; Zhang K; Kiselev E; Crane S; Wang J; Paoletta S; Yi C; Ma L; Zhang W; Han GW; Liu H; Cherezov V; Katritch V; Jiang H; Stevens RC; Jacobson KA; Zhao Q; Wu B
Nature; 2015 Apr; 520(7547):317-21. PubMed ID: 25822790
[TBL] [Abstract][Full Text] [Related]
79. Impaired cognition after stimulation of P2Y1 receptors in the rat medial prefrontal cortex.
Koch H; Bespalov A; Drescher K; Franke H; Krügel U
Neuropsychopharmacology; 2015 Jan; 40(2):305-14. PubMed ID: 25027332
[TBL] [Abstract][Full Text] [Related]
80. Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells.
Egan K; Crowley D; Smyth P; O'Toole S; Spillane C; Martin C; Gallagher M; Canney A; Norris L; Conlon N; McEvoy L; Ffrench B; Stordal B; Keegan H; Finn S; McEneaney V; Laios A; Ducrée J; Dunne E; Smith L; Berndt M; Sheils O; Kenny D; O'Leary J
PLoS One; 2011; 6(10):e26125. PubMed ID: 22022533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
